Compare Innodata Inc (INOD) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Innodata Inc vs DENTSPLY SIRONA Inc — how do they compare? Innodata Inc trades at $62.04 (market cap $2.10B), while DENTSPLY SIRONA Inc trades at $8.83 (market cap $1.73B). The key difference: Innodata Inc is the larger of the two by market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Innodata Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Innodata Inc for 19 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| INOD | XRAY | |
|---|---|---|
Market Cap | $2.10B | $1.73B |
Volume | 989,493 | 6,198,582 |
Sector | Technology | Health |
52-Week High | $121.50 | $14.68 |
52-Week Low | $34.45 | $8.52 |
Typical Hold Time | 19 Days | 72 Days |
Enterprise Value | $1.86B | $3.80B |
Dividend Yield | — | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INOD trades at $62.04, down 2.17% today, amid a bearish technical signal from moving averages. The company shows strong fundamentals with recent earnings beats, including Q2 2026 EPS of $0.41 versus $0.213 expected, and robust profitability with a 14.66% net income margin. Positive news highlights expansion into motion-capture AI labs and strategic board appointments, supporting growth in AI data services.
Outlook remains positive given earnings momentum and AI sector tailwinds, but risks include high valuation multiples like a P/E of 47.43 and customer concentration. Analyst consensus is bullish with 4 buy ratings, suggesting potential upside if execution continues.
DENTSPLY SIRONA (XRAY) trades at $8.83, down 3.4% with bearish technical signals. The stock faces fundamental challenges with negative net income margins (-14.99%) and declining revenue trends ($3.68B in 2025). Recent Q2 2026 earnings beat expectations but sales fell 4.1% amid ongoing turnaround efforts. The company maintains strong institutional interest despite hitting 52-week lows in September 2026.
XRAY presents a high-risk opportunity with Wall Street maintaining a cautious stance (37.5% buy rating). The consensus price target of $13.40 offers 52% upside potential, but investors face execution risks in the dental equipment turnaround, margin pressures, and competitive challenges. Near-term catalysts include management's presentation at the Baird Healthcare Conference in September 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Innodata Inc
Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.
Read more on INOD →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
